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This heterogeneous group of vascular anomalies, which
includes arterial, venous, capillary, and lymphatic
lesions, used to be frequently referred to as “angiomas”.
They have been since 1992 subdivided in two groups:
vascular malformations (or “angiodysplasias”) and the
rare true vascular tumours, which include immature
angiomas.
Vascular malformations
They are classified according to the type of vascular tis-
sue affected. They may be capillary, capillovenous,
venous, arterial, or lymphatic.
Capillary angiomas include telangiectasias (a central
vivid red point with fine, spreading branches), angioker-
atomas (small, dark-red structures covered by hyperker-
atosis), and flat angiomas (the classic “port wine” stain),
located mostly on the face and limbs. These are very dif-
ficult to treat because surgical excision leaves a signifi-
cant cosmetic sequela and laser treatment may have side
effects, such as pigmentation and keloid scarring.
Capillovenous angiomas produce a bluish subcutaneous
swelling, covered by a normal skin, which may progres-
sively increase in size. Although congenital by nature,
they can develop at any age in life. On physical examina-
tion, there is neither a palpable thrill nor a murmur.
Their size is variable, from a few mm3 to a large lesion
involving several fingers.
Imaging may be necessary in the case of large lesions.
Arteriogram has been supplanted by angio-MRI (or
MRA), which has become an important diagnostic and
therapeutic tool. Small lesions can be excised surgically.
The treatment of large lesions is difficult in the hand:
embolization carries a risk of digital necrosis, and surgical
excision, made difficult by the lack of a plane of dissec-
tion and the number of affected pedicles, is only recom-
mended in the localized forms.
In angiokeratomas, the associated skin involvement
may produce dramatic cosmetic impairment. Surgical
treatment is challenging in large lesions, involving skin
resection and coverage by means of various plastic
procedures.
Venous angiomas include cavernous angioma, which is
a simple ectasia arising from a vein and can be easily
removed or ligated, and dilatation of large veins, which
is much more difficult to treat.
Arterial angiomas include two different entities: arter-
ial aneurysm and arteriovenous angioma.
- Arterial aneurysms can be “false” when they arise from
an hematoma resulting from arterial laceration. The lesion
is saccular and histologically has neither elastic nor mus-
cular fibres. “True” aneurysms, more commonly found in
the hand, are due to a dilation of the arterial lumen. The
lesion is fusiform, and its wall contains elastic and muscu-
lar fibres. In both cases, the lesion is pulsatile with a systo-
lic thrill. The distal vascular status is assessed clinically by
the pulse, and Allen’s test; and radiologically by ultrasound
Doppler or an occasional MRI study. Surgical treatment
consists of excision of the lesion. If there is a satisfactory
collateral blood supply, microsurgical reconstruction may
not be required.
- Arteriovenous malformations are abnormal communi-
cations, or shunts, between an artery and a vein which
may be of traumatic or congenital origin. They may
remain latent until a second injury. A venous dilation in
the hand is suggestive of the diagnosis. There is a charac-
teristic thrill, a bruit, and an increase in local temperature.
Angio-MRI reveals the site of the communicating vessels
and the marked, excessively rapid venous return.
Surgery must be decided on cautiously in the congeni-
tal forms of arteriovenous malformations because of the
large number of shunting vessels and the possibility of
other latent shunts.
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Lymphangiomas are relatively rare. They may be
superficial and circumscribed or deep. Surgery involves
a risk of postoperative lymph fistula.
True vascular tumors
Immature angiomas are by far the most common vascu-
lar tumour. They appear during the first months of life.
Their natural history includes a growing phase until the
sixth month of life, a static phase until the twentieth
month, and a slow regression phase, which may last until
the sixth or seventh year and evolves to complete regres-
sion in about 90% of children. Surgery should only be
undertaken at the end of the regression phase for the very
rare sequelae.
Other vascular tumors are extremely rare. They
include hemangioendothelioma, hemangiopericytoma,
angioleiomyoma, and malignant tumors (angiosarcoma
and lymphangiosarcoma).
The first two types (hemangioendothelioma and
hemangiopericytoma) usually behave aggressively, and
histologic differentiation with a malignant tumor is often
uneasy. They require careful and frequent follow-up after
surgical excision.
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